Problems with intraoperative hyperthermic peritoneal chemotherapy for advanced gastric cancer

European Journal of Surgical Oncology

Volumn 26, Issue 3, 2000, Pages 222-226

  Samel, S ^a   Singal, A ^b   Becker, H ^b   Post, S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Complications; Gastric cancer; Intraperitoneal chemotherapy

Indexed keywords

CISPLATIN; MITOMYCIN;

ADULT; AGED; ANASTOMOSIS DEHISCENCE; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CHEMOSURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; FOLLOW UP; HEART FAILURE; HUMAN; HYPERTHERMIC THERAPY; KIDNEY FAILURE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; METASTASIS; PANCREAS FISTULA; PANCREATITIS; PERITONEUM CANCER; PILOT STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STOMACH CANCER; SURGICAL MORTALITY; TOTAL STOMACH RESECTION; TUMOR RECURRENCE;

EID: 0034067407     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0780     Document Type: Article

References (31)

1. Nakamura K, Ueyama T, Yao T, Xuan ZX, Ambe K, Adachi Y, Yakeishi Y, Matsukuma A, Enjoji M. Pathology and prognosis of gastric carcinoma. Cancer. 70:1992;1030-1037.
2. Takahashi T, Hagiwara A, Sawei K, Kondo S, Yamagushi T. Intensive intraoperative local chemotherapy for lymph node and peritoneal metastases in gastric cancer. Onkologie. 14:1991;152-157.
3. Yu CC, Levison DA, Dunn JA. Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer. Br J Cancer. 71:1995;1106-1110.
4. Ikeguchi M, Oka A, Tsujitani S, Maeta M, Kaibara N. Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer. Anticancer Res. 14:1994;2131-2134.
5. Gunderson L, Sosin H. Adenocarcinoma of the stomach: areas of failure in a reoperation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys. 8:1982;1-11.
6. Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Cancer. 73:1994;2048-2051.
7. Ikeguchi M, Kondou A, Oka A, Tsujitani S, Maeta M, Kaibara N. Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion. Eur J Surg. 161:1995;581-586.
8. Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with Mitomycin C. Cancer. 61:1988;232-237.
9. Yonemura Y. Contemporary approaches towards cure of gastric cancer. Kanazawa, Japan: Maeda Shoten Co. 1996;115.
10. Averbach AM, Jacquet P. Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer. Br J Surg. 83:1996;726-733.
11. Miwa K, Miyazaki I, Sahara H. Rationale for extensive lymphadenectomy in early gastric carcinoma. Br J Cancer. 72:1995;1518-1524.
12. Yonemura Y, Segawa M, Matsumoto H. Surgical results of performing R4 gastrectomy for gastric cancer located in the upper third of the stomach. Surg Today. 24:1994;488-493.
13. Furukawa H, Hiratsuka M, Iwanaga T. A rationale for surgical operation on Borrmann type 4 gastric carcinoma: left upper abdominal evisceration plus Appleby's method. Br J Surg. 75:1988;116-119.
14. Kehlsen DP. Adjuvant and neoadjuvant therapy for gastric cancer. Sem Oncol. 23:1996;379-389.
15. Wils J, Meyer HJ, Wilke H. Current status and future directions in the treatment of localised gastric cancer. Ann Oncol. 5 (Suppl. 3):1994;69-72.
16. Wils J. The treatment of advanced gastric cancer. Semin Oncol. 23:1996;397-406.
17. Tsuno T. Mechanisms of multidrug resistance and implications for therapy. Jpn J Cancer Res. 79:1988;285-296.
18. Yonemura Y, Fujimura T, Fushida S, Takegawa S, Kamata T, Katayama K, Kosaka T, Yamagushi A, Miwa A, Miyazaki I. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg. 15:1991;530-536.
19. Douglass HO. Rationale for the intraperitoneal approach to adjuvant chemotherapy of gastric cancer. In: Sugarbaker P (ed.) Management of Gastric Cancer. Boston: Kluwer Academic Publishers. 1991.
20. Elias D, Detroz B, Debaene B, Damia E, Leclercq B, Rougier P, Lasser P. Treatment of peritoneal carcinomatosis by intraperitoneal chemo-hyperthermia: reliable and unreliable concepts. Hepato-Gastroenterol. 41:1994;207-213.
21. Fujimura T, Yonemura Y, Muracka K, Takamura H, Hirono Y. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer. World J Surg. 18:1994;150-155.
22. Yonemura Y, Ninomija I, Kaji M, Sugiyama K, Fujimura T. Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg. 19:1995;450-455.
23. Wansik Y, Whang I, Uh I, Averbach A, Chang D, Sugarbaker PH. Prospective randomised trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg. 228:1998;347-354.
24. Yonemura Y, Fujimura T, Nishimura G. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery. 119:1996;437-444.
25. Sobin LH, Wittekind C (Hrsg.), International Union Against Cancer (UICC). TNM Classification of Malignant Tumours, 5th edition. New York: Wiley-Liss. 1997.
26. Post S, Samel S, Becker H. [On the risk of gastrectomy] Zum Risiko der Gastrektomie. Viszeralchirurgie. 33:1998;89-95.
27. Fujimoto S, Shresta D, Kokubun M, Kobayashi K, Kiuchi K, Takahashi M, Konno C, Ohota M, Koike S, Kitsukawa Y, Mizutani M, Okui K. Clinical trial with surgery and intraoperative hyperthermic perfusion for peritoneal recurrence of gastrointestinal cancer. Cancer. 64:1989;154-157.
28. Kern W, Kotschowsky M, Kaufmann CC, Braess J, Samel S, Becker H, Hiddemann W, Schleyer E. Pharmacokinetic basis of differences in Cisplatin induced nephrotoxicity following intraoperative hyperthermic intraperitoneal versus intravenous application. Reg Cancer Treat. Suppl. 1:1997;8.
29. Kuzuya T, Yamauchi M, Ito A, Hasegawa M, Hasegawa T, Nabeshima T. Pharmacokinetic characteristics of 5-Fluoro- uracil and Mitomycin C in intraperitoneal chemotherapy. J Pharm Pharmacol. 46:1994;685-689.
30. Sautner T, Hofbauer F, Depisch D, Schiessel R, Jakesz R. Adjuvant intraperitoneal Cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer. J Clin Oncol. 12:1994;970-974.
31. Jain RK. Barriers to drug delivery in solid tumours. Scientific Amer. 7:1994;42-49.